Impaired Insulin Secretion in Four Tangier Disease Patients with ABCA1 Mutations

1) Assmann G, Eckardstein A, Brewer HB: Familial analphalipoproteinemia: Tangier disease. The Metabolic and Molecular Bases of Inherited Diseases (McGraw Hill), 2001; 8th ed. vol 2: 2937-2960

10.1194/jlr.M600428-JLR200

10.1016/S0014-5793(00)02171-2

10.1074/jbc.M412564200

5) Brunham LR, Kruit JK, Pape TD, Timmins JM, Reuwer AQ, Vasanji Z, Marsh BJ, Rodrigues B, Johnson JD, Parks JS, Verchere CB, Hayden MR: Beta-cell ABCA1 influences insulin secretion, glucose homeostasis and response to thiazolidinedione treatment. Nat Med, 2007; 13: 340-347

6) Komuro R, Yamashita S, Sumitsuji S, Hirano K, Maru-yama T, Nishida M, Matsuura F, Matsuyama A, Sugimoto T, Ouchi N, Sakai N, Nakamura T, Funahashi T, Matsuzawa Y: Tangier disease with continuous massive and longitudinal diffuse calcification in the coronary arteries: demonstration by the sagittal images of intravascular ultrasonography. Circulation, 2000; 101: 2446-2448

10.1006/bbrc.2001.6219

8) Suehiro T, Takamatsu K, Yoshida K, Kawada M, Hisakata K, Yasuoka N, Kishino W, Uga S, Yamano T, Ohno F: A new case of Tangier disease Domyakukoka (in Japanese) 1985; 13: 967-974

10.1007/s100380200044

10) Ryo M, Nakamura T, Kihara S, Kumada M, Shibazaki S, Takahashi M, Nagai M, Matsuzawa Y, Funahashi T: Adiponectin as a biomarker of the metabolic syndrome. Circ J, 2004; 68: 975-981

10.1007/BF00280883

10.2337/dc05-1711

10.1016/j.metabol.2003.07.009

10.2337/db06-0905